Categorie
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Lopinavir
(89983914 | 192725-17-0)
CAS: | 192725-17-0 |
---|---|
Formula molecolare: | C37H48N4O5 |
Peso molecolare: | 628.80 |
Disponibilità: | In stock |
---|---|
Downloads: |
89983914-250mg | 250mg | £62.10 | |
Ordine all'ingrosso |
89983914-250mg | 250mg | €87.00 | |
Ordine all'ingrosso |
89983914-250mg | 250mg | $93.20 | |
Ordine all'ingrosso |
Specifiche
Certificato di analisi
Dettagli del prodotto
Product Code | 89983914 | ||||
Product Name | Lopinavir | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 192725-17-0 | ||||
Molecular Formula | C37H48N4O5 | ||||
Molecular Weight | 628.80 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29335995 |
Specifiche del prodotto
Specific rotation | -22° to -26° | ||||
Heavy metals | ≤ 20 ppm | ||||
Identification | Conforms to reference (IR,HPLC) | ||||
Residue on Ignition | <0.2% | ||||
Sulfated ash | ≤ 0.2% | ||||
Appearance | White to off white powder | ||||
Water content ( KF) | ≤ 4.0% | ||||
Assay (HPLC ) | 98% -102% | ||||
Version | To report |
Informazioni sulla sicurezza
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|